Roundhill Investments - GLP-1 & Weight Loss ETF (OZEM) Research
Roundhill considers weight loss medications, particularly GLP-1 agonists, to be among the most groundbreaking innovations currently reshaping the global pharmaceutical landscape. This conviction underpins the Roundhill GLP-1 & Weight Loss ETF (OZEM), which is distinguished as the world's inaugural ETF exclusively focused on the GLP-1 and broader weight management sector. Notably, OZEM employs an active management approach.
Market snapshot
- Symbol
- OZEM
- Price
- $30.39
- Day change
- -0.42%
- Market cap
- $39.0M
- 52-week range
- 23.22-37.15
- Sector
- Financial Services
- Industry
- Asset Management
Peer companies
- RiverNorth Active Income ETF (CEFZ)
- Franklin FTSE Asia ex Japan ETF (FLAX)
- Hoya Capital Housing ETF (HOMZ)
- KraneShares Emerging Markets Consumer Technology ETF (KEMQ)
- Neuberger Berman Japan Equity ETF (NBJP)
- Research Affiliates Deletions ETF (NIXT)
- WisdomTree Emerging Markets Efficient Core Fund (NTSE)
- Peakshares Sector Rotation ETF (PSTR)
Open Roundhill Investments - GLP-1 & Weight Loss ETF (OZEM) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.